← Back to all trials
Not Yet Recruiting
NCT05679648
Hepatic Steatosis and Fibrosis in Rheumatoid Arthritis Patients
Conditions: Hepatic Steatosis and Fibrosis in Rheumatoid Arthritis Patients
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: 1
Enrollment: 100
Sponsor: Sohag University
Summary
studying the prevalence of hepatic steatosis and fibrosis in a large scale of patients with RA and healthy controls
Eligibility Criteria
Inclusion Criteria:RA according to the American College of Rheumatology (ACR)/EULAR 2010 criteria (Aletaha et al., 2010)Age≥18 yearsExclusion Criteria:History of hepatitis B and C virus infection.Receiving hepatotoxic drugs other than RA-specific drugs.Alcohol abuse (i30 g/day in men and ⩾20 g/day in women).Diagnosis of Wilson's disease, α1-antitrypsin deficiency or hemochromatosis.Autoimmune liver disease.Cancer.Pregnancy.
Source: ClinicalTrials.gov (NCT05679648). StuddyBuddy aggregates publicly available trial information.
